SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Positive Results for SGX302 in Cohort 3 of Phase 2a Psoriasis Trial ...
As of Friday, December 26, Sol-Gel Technologies Ltd.’s SLGL share price has dipped by 5.05%, which has investors questioning if this is right time to buy.
That's because the natural ingredient is known as a superfood that can literally transform your body from the inside out, but ...
“Blush had a real moment in 2025, with lots of cool girls in Korea wearing blush high up on their cheeks, right below their ...
The Deer Park surgeon is accused of copying and pasting 43 virtually identical reports over a four-year period.
Dark circles can affect self-esteem and facial appearance. Here are some skincare hacks that can be used to remove dark ...
Detailed price information for Pelthos Therapeutics Inc (PTHS-A) from The Globe and Mail including charting and trades.
“Andrew’s extensive capital markets and in-house finance experience make him a strong addition to the Pelthos Board of Directors,” said Peter Greenleaf, Chairman of the Board. “His experience ...
TipRanks on MSN
Pelthos Therapeutics acquires global rights to Xeglyze
Pelthos Therapeutics ( ($PTHS) ) just unveiled an announcement. On December 23, 2025, Pelthos Therapeutics acquired from Australian biotech ...
Fluoride remains the cornerstone of preventive dentistry, and researchers have analyzed the many delivery methods of fluoride ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results